General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0ZAFBL
ADC Name
IBI-129
Synonyms
IBI-129; IBI 129; IBI129
   Click to Show/Hide
Organization
Innovent Biologics, Inc.
Drug Status
Phase 1/2
Indication
In total 1 Indication(s)
Solid tumor
Phase 2
Clinical Trial
Drug-to-Antibody Ratio
Undisclosed
Antibody Name
Undisclosed
Antigen Name
CD276 antigen (CD276)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed
Conjugate Type
Undisclosed